Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population
Mohamad Saad(Université Toulouse III - Paul Sabatier), Jean‐Charles Lambert(Inserm), Marie Vidailhet(School of the Art Institute of Chicago), George D. Mellick(Griffith University), E. Broussolle, Ebba Lohmann(Centre National de la Recherche Scientifique), F. Durif(Centre Hospitalier Universitaire de Clermont-Ferrand), Michael Borg(Max Planck Institute for Developmental Biology), Catherine Helmer(Inserm), Christine Tranchant(Hôpitaux Universitaires de Strasbourg), Alexis Brice(School of the Art Institute of Chicago), Marc Vérin, Marie‐Anne Loriot(Inserm), Philippe Amouyel(Institut Pasteur de Lille), Muriel Bonnet(Université Clermont Auvergne), María Martínez(Inserm), Sylvie Forlani(Centre National de la Recherche Scientifique), Olivier Rascol(Université Toulouse III - Paul Sabatier), Christophe Tzourio(The University of Sydney), Alexis Elbaz(Université Paris-Sud), Maurice Giroud(Centre Hospitalier Universitaire Dijon Bourgogne), Sonja Klebe(Flinders Medical Centre), Suzanne Lesage(Centre National de la Recherche Scientifique), Diana Zélénika(Centre National de Recherche en Génomique Humaine), Philippe Damier(Inserm), Mathieu Anheim(Centre National de la Recherche Scientifique), Mark Lathrop(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Christiane Penet(Centre Hospitalier Universitaire de Grenoble), François Tison(Institut des Maladies Neurodégénératives), Florence Portet(Inserm), Alexandra Dürr(Centre National de la Recherche Scientifique), Peter A. Silburn(Griffith University), Yves Agid, François Viallet(Centre National de la Recherche Scientifique), Aude Saint-Pierre(Université Toulouse III - Paul Sabatier), A. Destée(Inserm), Jean‐Christophe Corvol(Centre National de la Recherche Scientifique), Pierre Pollak(School of the Art Institute of Chicago)
Cited by 161
Related Papers
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.6k